OppenheimerFunds’s Core Laboratories CLB Stock Holding History

OppenheimerFunds’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,778	Closed	-$206K	–	1807
2018 Q3	$206K	Buy	+1,778	New	+$201K	﹤0.01%	1775
2016 Q4	–	Sell	-32,809	Closed	-$3.69M	–	1791
2016 Q3	$3.69M	Sell	32,809 -31,741	-49%	-$3.66M	﹤0.01%	840
2016 Q2	$8M	Buy	+64,550	New	+$7.79M	0.01%	755
2014 Q2	–	Sell	-42,930	Closed	-$8.52M	–	939
2014 Q1	$8.52M	Buy	42,930 +11,380	+36%	+$2.15M	0.01%	777
2013 Q4	$6.02M	Buy	+31,550	New	+$5.87M	0.01%	812

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

OppenheimerFunds's CLB Position: Q4 2018 in Review

OppenheimerFunds sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 1,778 shares — an estimated $206K sold.

OppenheimerFunds first reported a position in CLB in Q4 2013 and held it in 5 quarters. The position peaked at $8.52M in Q1 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

OppenheimerFunds reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
OppenheimerFunds sold 1,778 Core Laboratories shares in Q4 2018, an estimated $206K.
OppenheimerFunds first reported a position in Core Laboratories in Q4 2013 and held it in 5 quarters.
OppenheimerFunds's Core Laboratories position peaked at $8.52M in Q1 2014.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.